cancers-logo

Journal Browser

Journal Browser

Endoscopic Diagnosis and Treatment of Early Gastric Cancer: Current Evidence and What the Future May Hold

A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: closed (20 October 2021) | Viewed by 3672

Special Issue Editor


E-Mail Website
Guest Editor
1. Lyell McEwin Hosp, Gastroenterology Dept, Elizabeth Vale, SA, Australia
2. University of Adelaide, Faculty of Health & Medical Sciences, Adelaide, SA, Australia
Interests: Endoscopic Imaging and Resection, Early GI cancer

Special Issue Information

Dear Colleagues,

The most common form of gastric cancer develops through a well-established precancerous inflammatory cascade pathway. The first stage, active chronic inflammation, progresses from non-atrophic gastritis to multifocal atrophic gastritis, gastric intestinal metaplasia, dysplasia, and eventually early and finally invasive cancer. This development therefore allows the ability to recognise patients at high risk of gastric cancer, who could then be subjected to regular screening in order to detect progression at an earlier and more readily treatable stage. 

Endoscopic biopsy in necessary for the diagnosis and characterization of precancerous gastric lesions. Modern endoscopy imaging technologies have shown increased accuracy in the detection and characterisation of these lesions. White Light Endoscopy is the standard endoscopy imaging technique but has limitations in identifying less obvious abnormalities such as flat precancerous lesions. This can result in either missed or misidentified lesions. Conversely, chromoendoscopy and virtual/electronic chromoendoscopy techniques have been used to aid the endoscopist in identifying dysplasia or early gastric cancer by enhancing the visualization of superficial mucosal and vascular structures. Lesions which are detected can be addressed using minimally invasive advanced endoscopic techniques including Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). This can result in a complete cure without the need for surgery and the associated risks to the patient and costs to the healthcare system. 

This review will focus on up-to-date information on the inflammatory cascade in the development of gastric cancer as well as novel endoscopic imaging modalities available to detect dysplasia and gastric cancer and endoscopic treatment modalities that are available to address these lesions.

Dr. Rajvinder Singh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • early gastric cancer
  • dysplasia
  • gastric atrophy
  • gastric intestinal metaplasia
  • Helicobacter Pylori
  • advanced mucosal imaging, Artificial Intelligence
  • Endoscopic Mucosal Resection
  • Endoscopic Submucosal Dissection

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

8 pages, 496 KiB  
Brief Report
Increased Reflux Esophagitis after Helicobacter pylori Eradication Therapy in Cases Undergoing Endoscopic Submucosal Dissection for Early Gastric Cancer
by Masaki Katsurahara, Ichiro Imoto, Yuhei Umeda, Hiroshi Miura, Junya Tsuboi, Reiko Yamada, Taro Yasuma, Misaki Nakamura, Yasuhiko Hamada, Hiroyuki Inoue, Kyosuke Tanaka, Noriyuki Horiki, Esteban C. Gabazza and Yoshiyuki Takei
Cancers 2021, 13(8), 1779; https://doi.org/10.3390/cancers13081779 - 8 Apr 2021
Cited by 3 | Viewed by 2744
Abstract
Background: The role of Helicobacter pylori in the pathogenesis of reflux esophagitis is controversial. This study investigated the frequency of reflux esophagitis before and after H. pylori eradication in patients having endoscopic submucosal dissection for early gastric cancer. Methods: This study included 160 [...] Read more.
Background: The role of Helicobacter pylori in the pathogenesis of reflux esophagitis is controversial. This study investigated the frequency of reflux esophagitis before and after H. pylori eradication in patients having endoscopic submucosal dissection for early gastric cancer. Methods: This study included 160 patients that fulfilled the study’s criteria. Endoscopy was performed before and after H. pylori eradication, and reflux esophagitis was evaluated during the follow-up period. Results: Seropositivity for H. pylori in patients with early gastric cancer was 68.8%, 101 of them received eradication therapy. During the follow-up period, the incidence of reflux esophagitis increased from 3.1% to 18.8% in the successful eradication group but no case of reflux esophagitis was observed in the failed eradication group. The univariate and multivariate analyses showed a significant correlation between successful H. pylori eradication rate and the development of reflux esophagitis. Conclusions: This study demonstrated that a successful H. pylori eradication therapy is a risk factor for newly developed reflux esophagitis in patients with endoscopic submucosal dissection for early gastric cancer. Full article
Show Figures

Figure 1

Back to TopTop